65G-22484-86341 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-15
Registered in v-safe
2021-03-15
Dose 1 — Pfizer-BioNTech
2021-03-15
Health check-in — day 0, dose 1
Feeling: Fair · Headache, Fatigue or tiredness

Adult check-in
2021-03-16
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea, Abdominal pain

Adult check-in
2021-03-22
Health check-in — day 7, dose 1
Feeling: Fair · None

Adult check-in
2021-04-05
Dose 2 — Pfizer-BioNTech
2021-04-28
Health check-in — day 21, dose 2
Feeling: Fair

Adult check-in
2021-05-12
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-17
Health check-in — day 42, dose 2
Feeling: Fair

Adult check-in
2021-07-05
Survey response — 3 months, dose 2
MedDRA: Brain fog, Cognitive disorder, Disturbance in attention, Dizziness, Fatigue, Headache, Impaired work ability, Malaise, Mental impairment, Nausea — Feeling: Good · Be unable to work or attend school

Free text: Two weeks ago, I felt so ill I could not work or feel confident in my cognition. Light-headed, dizziness, headache, desire to rest, inability to focus or think, nausea. There were trace effects lasting upwards of five days. Curious if delta, no test.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-10-04
Survey response — 6 months, dose 2
MedDRA: Fatigue — Feeling: Fair

Free text: Fatigue and regular exhaustion.

MedDRA releases: 2024-11 · check-in free text available
2022-04-07
Survey response — 12 months, dose 2
MedDRA: Brain fog, Disturbance in attention, Fatigue, Fine motor skill dysfunction, SARS-CoV-2 test negative, Somnolence — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Cloudy head, unusually strong fatigue, poor motor skills, can't focus or observe, strong desire to sleep. Occurred four times in five months, four administered Covid tests said negative.

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-15	Pfizer-BioNTech
2	2021-04-05	Pfizer-BioNTech

Free text

Release 9 — 3 months, dose 2

2021-07-05

Symptoms: Two weeks ago, I felt so ill I could not work or feel confident in my cognition. Light-headed, dizziness, headache, desire to rest, inability to focus or think, nausea. There were trace effects lasting upwards of five days. Curious if delta, no test. cut off by CDC

Release 10 — 6 months, dose 2

2021-10-04

Symptoms: Fatigue and regular exhaustion.

Release 11 — 12 months, dose 2

2022-04-07

Symptoms: Cloudy head, unusually strong fatigue, poor motor skills, can't focus or observe, strong desire to sleep. Occurred four times in five months, four administered Covid tests said negative.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Brain fog	✓	✓	✓
SD	Cognitive disorder	·	·	✓
SD	Disturbance in attention	·	·	✓
SD	Dizziness	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Fine motor skill dysfunction	·	·	✓
SD	Headache	✓	✓	✓
SD	Impaired work ability	·	·	✓
SD	Malaise	·	·	✓
SD	Mental impairment	·	·	✓
SD	Nausea	✓	✓	✓
SD	SARS-CoV-2 test negative	·	·	✓
SD	Somnolence	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release